Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Biofrontera AG
  6. News
  7. Summary
    B8F   DE0006046113

BIOFRONTERA AG

(B8F)
  Report
Delayed Quote. Delayed Xetra - 06/18 11:36:13 am
2.91 EUR   -1.36%
06/18European ADRs Down More Than 2% Friday as Banks, Drillers Drop
MT
06/16European ADRs Flat in Wednesday Morning Trading
MT
06/14European ADRs Move Higher in Monday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Slightly Higher in Thursday Trading

05/06/2021 | 11:11am EDT


© MT Newswires 2021
All news about BIOFRONTERA AG
06/18European ADRs Down More Than 2% Friday as Banks, Drillers Drop
MT
06/16European ADRs Flat in Wednesday Morning Trading
MT
06/14European ADRs Move Higher in Monday Trading
MT
06/07BIOFRONTERA  : reports preliminary revenue for the month of May 2021 (Form 6-K)
PU
06/07Biofrontera reports preliminary revenue for the month of May 2021
GL
06/07PTA-NEWS : Biofrontera AG: Biofrontera reports preliminary revenue for the month..
PU
05/26European ADRs Trading Nearly Flat Wednesday; IDEX a Standout
MT
05/25European ADRs Little Changed as Energy Giants Slip
MT
05/24European ADRs Move Higher in Monday Trading
MT
05/20European ADRs Move Higher in Thursday Trading
MT
More news
Financials
Sales 2021 29,3 M 34,8 M 34,8 M
Net income 2021 -19,1 M -22,6 M -22,6 M
Net Debt 2021 - - -
P/E ratio 2021 -8,69x
Yield 2021 -
Capitalization 165 M 196 M 196 M
Capi. / Sales 2021 5,63x
Capi. / Sales 2022 4,15x
Nbr of Employees 154
Free-Float 46,4%
Chart BIOFRONTERA AG
Duration : Period :
Biofrontera AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIOFRONTERA AG
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 6,80 €
Last Close Price 2,91 €
Spread / Highest target 134%
Spread / Average Target 134%
Spread / Lowest Target 134%
EPS Revisions
Managers and Directors
NameTitle
Hermann Lübbert Chairman-Management Board & CEO
Ludwig Lutter Chief Financial Officer
Ulrich Granzer Chairman-Supervisory Board
Jürgen Christian Baumann Vice Chairman-Supervisory Board
Kevin D. Weber Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
BIOFRONTERA AG-1.93%199
CSL LIMITED7.89%103 997
WUXI BIOLOGICS (CAYMAN) INC.28.50%65 667
BIOGEN INC.56.63%57 741
SAMSUNG BIOLOGICS CO.,LTD.1.21%48 638
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.21.49%44 390